| NDC Code | 70860-776-02 |
|---|
| Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (70860-776-02) / 2 mL in 1 VIAL, SINGLE-DOSE (70860-776-41) |
|---|
| Product NDC | 70860-776 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ondansetron |
|---|
| Non-Proprietary Name | Ondansetron Hydrochloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS |
|---|
| Start Marketing Date | 20170101 |
|---|
| End Marketing Date | 20251031 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA079224 |
|---|
| Manufacturer | Athenex Pharmaceutical Division, LLC. |
|---|
| Substance Name | ONDANSETRON HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
|---|